| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Salarius Pharmaceuticals, Inc. ("Salarius" or the "Company") (NASDAQ:SLRX) today announced the pricing of an un...
As previously disclosed, Salarius Pharmaceuticals, Inc. (the "Company") entered into an Agreement and Plan of Merger da...